|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
HIV Genotype
Test CodeHIV GENOTYPE PANEL 2015(WH)
Includes
RT MUTATIONS
Emtricitabine
Lamivudine
Zidovudine
Didanosine
Tenoflovir
Stavudine
Abacavir
Rilpivirine
Etravirine (ETR)
Efavirenz
Nevirapine
PROTEASE MUTATIONS
Tipranavir
Indinavir (IDV)
Lopinavir Ritonavir
Fosamprenavir
Darunavir
Atazanavir
Nelfinavir
Emtricitabine
Lamivudine
Zidovudine
Didanosine
Tenoflovir
Stavudine
Abacavir
Rilpivirine
Etravirine (ETR)
Efavirenz
Nevirapine
PROTEASE MUTATIONS
Tipranavir
Indinavir (IDV)
Lopinavir Ritonavir
Fosamprenavir
Darunavir
Atazanavir
Nelfinavir
Preferred Specimen
Plasma from two lavender top EDTA tubes
Transport Temperature
Frozen
Methodology
Trugene HIV genotyping assay
Limitations
Routinely, the assay will be performed only on samples that have a viral load higher than 1,000 copies/ml, because the sequencing of samples with viral load lower than 1,000 copies is not consistently successful. If a recent HIV RNA viral load (1-2 weeks) is not available, a viral load test will be ordered and performed before the sample is tested for HIV genotyping. Genotyping of samples with viral load lower than 1,000 copies will be attempted only if specifically requested.
Reference Range
No mutations detected.
Clinical Significance
HIV-1 genotyping assays are recommended for patients who experience treatment failure on their first or subsequent regimen. HIV genotyping should also be considered in patients with primary infection, and in patients with established infections that have not yet been treated.
Performing Laboratory
Test performed at the VA Connecticut Virology Lab
Contact: Dr. David Peaper 203-937-3441
Additional Information
Link to March 2015 Newsletter
Last Updated: January 15, 2016